Are you Dr. Brand?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3 Electronics Ave
Ste 201
Danvers, MA 01923Phone+1 978-750-0300Fax+1 978-279-1324
Summary
- Dr. Stephen Brand, MD is a gastroenterologist in Danvers, Massachusetts. He is currently licensed to practice medicine in Massachusetts, Connecticut, and Maine. He is affiliated with Encompass Health Rehabilitation Hospital of Western Massachusetts.
Education & Training
University of Western Australia Faculty of MedicineClass of 1975
Certifications & Licensure
MA State Medical License 1990 - 2026
ME State Medical License 2013 - 2026
NH State Medical License 2012 - 2026
RI State Medical License 2012 - 2026
CT State Medical License 2015 - 2025
Publications & Presentations
PubMed
- 94 citationsSpasmolytic polypeptide: A trefoil peptide secreted by rat gastric mucous cellsGary P. Jeffrey, Phillip S. Oates, Timothy C. Wang, Mark W. Babyatsky, S J Brand
Gastroenterology. 1994-02-01 - 229 citationsPancreatic gastrin stimulates islet differentiation of transforming growth factor alpha-induced ductular precursor cells.Timothy C. Wang, Susan Bonner-Weir, PS Oates, M Chulak, B Simon
The Journal of Clinical Investigation. 1993-09-01 - 10 citationsA rat gastrin-human gastrin chimeric transgene directs antral G cell-specific expression in transgenic miceT C Wang, Mark W. Babyatsky, PS Oates, Zhe Zhang, L. Tillotson
The American Journal of Physiology. 1995-06-01
Press Mentions
Mycovia Pharmaceuticals Announces Positive Topline Results from Its Third Phase 3 Clinical Trial (ultraVIOLET) of Oteseconazole for the Treatment of Recurrent Vulvovaginal CandidiasisJanuary 6th, 2021- Mycovia Pharmaceuticals Announces Positive Topline Results from Phase 3 VIOLET Studies of Oteseconazole in Patients with Recurrent Vulvovaginal CandidiasisDecember 9th, 2020
- Mycovia Pharmaceuticals Announces Peer-Reviewed Publication of Positive Study Results of Oteseconazole for the Treatment of Acute Vulvovaginal CandidiasisAugust 26th, 2020
- Join now to see all
Grant Support
- Gut Peptide Expression In The Endocrine PancreasNational Institute Of Diabetes And Digestive And Kidney Diseases1991–1993
- Physiological Regulation Of Gastrin Gene ExpressionNational Institute Of Diabetes And Digestive And Kidney Diseases1988–1992
- Gut Pepitde Expression In The Endocrine PancreasNational Institute Of Diabetes And Digestive And Kidney Diseases1990
